NOV 16, 2015 02:18 PM PST

Harnessing the Power of NK Cells to Fight Cancer

WRITTEN BY: Kara Marker
In the fight against cancer, immunotherapy is increasingly becoming a promising treatment option since it revolves around helping the body enhance its natural cancer-killing abilities. This week, scientists from the Institut de Recherches Cliniques de Montreal (IRCM) have discovered a new target for antibodies in immunotherapy development. 

Natural killer (NK) cells are lymphocytes that specialize in killing cancer cells. However, sometimes the action of NK cells is not enough to prevent the progression of cancer in the body. The group from IRCM looked to identify the mechanism behind the anti-cancer NK cell behavior with the idea of harnessing this action for use in immunotherapies. As described in their recent paper published in the Journal of Experimental Medicine, they finally discovered how an NK cell surface protein, DNAM-1, provided the stimulation behind the lymphocyte's cancer-killing tendencies. 
Various NK cell surface proteins

DNAM-1 competes with other surface receptors that might impede the cancer-killing action of NK cells. For example, the TIGIT receptor reduces NK cell efficiency. 

"When the TIGIT receptor interacts with an infected cell, it prevents its interaction with the DNAM-1 protein, which, as a result, suppresses the function of NK cells and slows the immune system," explained Dr. Andrew Veillette, leader of the IRCM study. 

As a cancer immunotherapy target, scientists could harness the action of DNAM-1 in the form of anti-TIGIT antibodies and other receptor blockers to enhance the natural cancer-fighting function of DNAM-1.

"This type of therapy could have a significant impact on the next generation of cancer treatments."

Watch the following video to learn more about different targets in the realm of cancer immunotherapy.
 
Source: IRCM
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAY 01, 2018
Immunology
MAY 01, 2018
A Vaccine for When Horses Get the Flu
Horses, like humans, are susceptible to infections by the influenza virus. And like other animals, horses are capable of spreading the flu to humans, so va...
JUN 13, 2018
Immunology
JUN 13, 2018
Vitamin A Gives Immune System Power to Fight Tuberculosis
Multidrug-resistant tuberculosis bacteria are a serious health concern for the global population, but a new finding offers a new therapeutic solution that...
JUL 18, 2018
Immunology
JUL 18, 2018
Immunotherapy Increases Survival of Melanoma Brain Metastases Patients
Use of Checkpoint Blockade Immunotherapy increases survival rates in Melanoma Brain Metastases patients, with a 4-year survival rate increase from 11.1% to 28.1%...
AUG 15, 2018
Immunology
AUG 15, 2018
Therapeutic Macrophages Improve Rare Lung Disorder
The use of therapeutic macrophage transplantation in mice showed great improvement in rare lung disorder caused by deficient macrophages....
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
SEP 11, 2018
Immunology
SEP 11, 2018
Oops! I Broke My DNA
Innate Immune System, DNA Damage and Repair...
Loading Comments...